舒利迭治疗慢性阻塞性肺病的临床分析

Clinical Analysis on COPD Treated with Seretide

[目的]观察舒利迭治疗慢性阻塞性肺病(COPD)的疗效。[方法]选择COPD患者60例,随机分为治疗组30例和对照组30例,在常规治疗基础上对照组吸入普米克都保,治疗组吸入舒利迭。根据圣.乔治(St.George)呼吸疾病问卷(SGRQ)的方法,进行临床症状及体症检查评分,测定肺功能指标FEV1,FEV1/FVC及FEV1占预计值(%)来评价治疗前后肺功能的变化。[结果]舒利迭组治疗后临床症状及肺功能指标明显优于对照组(P<0.05)。[结论]舒利迭是治疗COPD的有效药物,使用安全。

[Objective]To observe the effects of Seretide in the treatment of chronic obstructive pulmonary disease(COPD).[Methods]60 cases of COPD from respiratory department were randomly divided into treatment group and control group,which base on routine treatment,the control group was given inhaled Budesonide,the treatment group was given inhaled Seretide.According to the methods of standard grade of respiratory diseases questionnaire(SGRQ)introduced by St.George,the clinical symptom and physical sign were graded,the percentage of pulmonary functional parameters include FEV1,FEV1/FVC and FEV1 prediction value(%)were examined and then the pulmonary functional changes before and after therapy were evaluated.[Results]Clinical symptom and pulmonary functional parameters in the treatment group were significantly improved compared with control group.[Conclusions]Seretide is effective and safety to COPD,so it is worth to generalize in clinical treatment.